Case Study 2 - Benzodiazepines and Combinatorial Chemistry Flashcards

1
Q

Ring A and drawing

A

Ring A involved in pie-pie stacking in the receptor protein

Exchanging ring A for a heterocyclic ring leads to lower anxiolytic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ring B drawing

A

slide 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ring C and drawing

A

• Ring C may contribute to steric or hydrophobic interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What Is Combinatorial Chemistry?

A
  • A process where groups of starting materials are reacted together to make every available product
  • Mixtures of products are obtained – a library
  • Useful for making very diverse mixtures of compounds with drug-like properties for screening
  • One set of starting materials may be fixed on a solid support – solid-phase synthesis
  • Can be totally automated, increase productivity
  • Introduces diversity in lead compound structure
  • Rational versus Irrational drug design
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What Is A Compound Library?

A
  • A collection of compounds prepared for testing
  • A library contains very little of each compound
  • Several types of library can be prepared:
  • Virtual: in silico
  • General: no bias for a target
  • Discovery: a library with drug-like features
  • Focused: designed to inhibit a target family
  • Targeted: designed to inhibit a specific target
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Orthodox synthesis:

A

A+B –> AB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Making a Simple Library

A
  • Parallel synthesis, spatially addressable

* 96- or 384-well plates, ready for HTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

‘Mix And Split’ Library Synthesis

A
  • Substrates are attached to a solid support
  • Reactions are driven to completion by using excess reagent
  • Screening issues
  • Positive results must be deconvoluted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Solid Phase Organic Chemistry 1 - methodology

A
  • The development of automated solid-supported peptide synthesis revolutionised peptide research
  • The automated methodology has been adapted to make many peptides in parallel
  • All of the chemistry required has been worked out so combinatorial synthesis of peptides is easy
  • The methodology can also be applied to the synthesis of any small-molecule library using combinatorial chemistry on a solid support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Solid Phase Organic Chemistry

• Wang linker

A
  • Suitable for a base-labile protecting group strategy
  • Requires 1% - 95% TFA for cleavage
  • Reveals CO2H
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Screening Compound Libraries

A
  • Screen the library in solution
  • Must cleave all compounds from the support
  • Possibility of false or misleading hits
  • Must resynthesize all compounds in an active library
  • Screen individual compounds in solution
  • Separate the beads manually
  • Requires a method for identifying active structures
  • Screen compounds still attached to the support
  • Colorimetric/ fluorimetric assay
  • Support can restrict the conformation of the product
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hit Structure Determination

A
  • The active hit must be prepared on a larger scale once activity has been found
  • Structure determination can be the rate-limiting step
  • Ideally, the structure of the hit would be determined whilst the compound is still anchored to the solid support
  • Nanomolar quantities of the hit can not be characterised easily using spectroscopy so some other methodology, chemical or otherwise, is required to trace the hit structure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Matrix Metalloproteinase (MMP) Enzymes

A
  • A family of zinc-dependant enzymes
  • Degradation and remodeling of the extracellular matrix
  • Important therapeutic targets with indications in cancer, arthritis, autoimmunity, and cardiovascular disease
  • Selectivity is important for therapy
  • Diketopiperazine (DKP) enzyme inhibitors chosen as lead compounds following de novo drug design
  • Solid-phase combinatorial synthesis chosen as a route to develop a diverse array of analogues for screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Benzodiazepines

A

Class A

Class B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Benzodiazepines Class A

A

Clonazepam Diazepam
Lorazepam
Oxazepam Temazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Benzodiazepines Class B

A

Alprazolam
Estazolam
Midazolam
Triazolam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clonazepam

A
Class A
R1 - H
R3 - H
R7 - NO2
X - Cl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diazepam

A
Class A
R1 - CH3
R3 - H
R7 - Cl
X - H
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lorazepam

A
Class A
R1 - H
R3 - OH
R7 - Cl
X - Cl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Oxazepam

A
Class A
R1 - H
R3 - OH
R7 - Cl
X - H
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Temazepam

A
Class A
R1 - CH3
R3 - OH
R7 - Cl
X - H
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Alprazolam

A

Class B
R - CH3
X - H
Y - N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Estazolam

A

Class B
R - H
X - H
Y - N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Midazolam

A

Class B
R - CH3
X - F
Y - CH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Triazolam

A

Class B
R - CH3
X - Cl
Y - N

26
Q

Ring A - position 7

A

An electronegative group in position 7 markedly increases the functional anxiolytic activity

27
Q

Ring A - position 6,8,9

A

Substituents in 6, 8 or 9 positions decrease anxiolytic activity

28
Q

Ring B - position 1

A

• Alkylation of the amide nitrogen in position 1 with sterically undemanding groups does not affect activity significantly

29
Q

Ring B - position 2

A
  • A proton accepting group in position 2 of Ring B is essential, coplanar with Ring A
  • Substituting sulfur or oxygen in position 2 does not affect anxiolytic activity significantly
30
Q

Ring B - position 3

A
  • Substitution on the methylene group at position 3 has no effect on anxiolytic (agonist) activity but decreases antagonist activity
  • The stereochemistry of hydroxylation at position 3 does not affect activity
  • The stereochemistry at position 3 may be important for steric interactions at the receptor with one enantiomer being favoured
31
Q

Ring B - position 4,5

A

• The 4-5 C=N bond is essential for in vivo activity

32
Q

Ring C - position 2

A

Substitution at position 2’ is not detrimental to agonist activity

33
Q

Ring C - position 4

A

Substitution at position 4’ is unfavourable due to steric interactions

34
Q

Oxazepam metabolism S

A

Oxazepam S –> (UGT2B15) S-oxazepam glucuronide

70 - 85%

35
Q

Oxazepam metabolism R

A

Oxazepam R –> (UGT1A9, UGT2B7) R-oxazepam glucuronide

15-30%

36
Q

Metabolism of Alprazolam

A

CY3A5, CYP3A4 –> Hydroxylation –> Glucuronidation –> Elimination

37
Q

Metabolism of Triazolam

A

CY3A5, CYP3A4 –> Hydroxylation –> Glucuronidation –> Elimination

38
Q

Metabolism of Midazolam

A

CYP3A4 –> Hydroxylation –> UGT1A4, UGT2B7 UGT2B4 –> Glucuronidation –> Elimination

UGT1A4 –> Glucuronidation –> Elimination

39
Q

Metabolism of Flurazepam

A

Hydroxylation/ alkylation –> Glucuronidation –> Elimination

40
Q

Metabolism of Bromazepam

A

CYP1A2, CYP2D6 –> Hydroxylation –> Glucuronidation –> Elimination

41
Q

Metabolism of Lorazepam

A

UGT2B15 –> Glucuronidation –> Elimination

42
Q

Metabolism of Clonazepam

A

NAT2 –> Acetylation –> Elimination

43
Q

Metabolism of Diazepam

A

CYP2C19 –> Nordazepam

CYP3A4 –> Tempazepam –>

44
Q

Metabolism of Nordazepam

A

CYP3A4 –> S-oxazepam

45
Q

Metabolism of Temazepam

A

CYP2C19 –> R-oxazepam

46
Q

difference in oxazepam and diazepam

A

oxazepam has an extra OH next C=O

47
Q

difference in flurazepam and quazepam

A

quazepam has C=S instead of C=O in flurazepam

quazepam has N-CF3 instead of N-CH2-CH2-N in flurazepam

48
Q

difference in estazolam, triazolam, temazepam

A

triazolam has extra CH3 bound to N ring than estazolam

temazepam has an extra C=O and -OH bound to N ring than triazolam

49
Q

Solid Phase Organic Chemistry 2 - each substrate

A
  • Each substrate is attached to a polymer bead
  • All reactions are driven to completion by using an excess of reagent
  • The final products are separated easily from the reaction mixture by filtration
  • By-products and excess reagents can be washed off the solid support, leaving pure product to be cleaved from the bead
50
Q

Solid Phase Organic Chemistry 3 - polymeric support

A
  • The polymeric support must be insoluble and inert to the reaction conditions employed
  • The means of linking the substrate to the solid support must allow efficient and selective cleavage of some or the entire quantity of product from the solid support
  • A protecting group strategy must be used which allows selective protection and deprotection of all reactive groups in the building blocks to be used and the supported substrate
51
Q

Solid Phase Organic Chemistry 4 - most widely used

A
  • The most widely used solid supports are cross-linked polystyrene beads
  • The local environment around the polystyrene bead can limit the range of possible reactions
  • Sheppard’s resin is a polyamide and provides a more suitable environment for peptide synthesis
  • Tentagel resin has polyethylene glycol residues tethered to polystyrene beads
  • The surface environment of Tentagel beads is hydrophilic but also like a polar organic solvent
52
Q

Solid Phase Organic Chemistry 5 - linker group

A
  • The linker group provides a means by which the substrate is attached to the polymer bead
  • The linker dictates what chemistry the growing substrate will withstand, the conditions required to release the library from the solid phase and what functionality will be revealed
  • Merrifield resin, developed for peptides: requires HF to cleave the product from the bead, reveals CO2H
53
Q

Fluoroquinolone Antibiotics

A

Ciprofloxacin
Levofloxacin
Gatifloxacin
Moxifloxacin

54
Q

Fluoroquinolone Synthesis

A

Diagram - slide 27

55
Q

SPOS Fluoroquinolone Synthesis

A

Diagram - slide 30

56
Q

Library DKP-1

A

L-cysteine gives 19 x 18 = 342 compounds
D-cysteine gives 19 x 18 = 342 compounds

Library DKP-1: Total of 684 compounds in pools of 19 DKPs

57
Q

Library DKP-2

A

L-cysteine gives 19 x 18 = 342 compounds
D-cysteine gives 19 x 18 = 342 compounds

Library DKP-2: Total of 684 compounds in pools of 19 DKPs

58
Q

Most selective inhibitor for Collagenase 1

A

R1 : PhCH2

R2 : p-CH3OC6H4

59
Q

Least selective inhibitor

A

R1 : n-Butyl

R2 : C6H11

60
Q

Best candidate for optimisation for Gelatinase B Inhibitor

A

R1 : C6H11CH2

R2 : p-CH3OC6H4